Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-3-10
pubmed:abstractText
To assess incidence, risk factors, histology, and outcome of severe hepatotoxicity (SH) during antiretroviral treatment (ART).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1525-4135
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
259-67
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12626885-Adult, pubmed-meshheading:12626885-Alanine Transaminase, pubmed-meshheading:12626885-Anti-HIV Agents, pubmed-meshheading:12626885-Antiviral Agents, pubmed-meshheading:12626885-Biopsy, pubmed-meshheading:12626885-CD4 Lymphocyte Count, pubmed-meshheading:12626885-Cohort Studies, pubmed-meshheading:12626885-Drug Therapy, Combination, pubmed-meshheading:12626885-Drug-Induced Liver Injury, pubmed-meshheading:12626885-Female, pubmed-meshheading:12626885-HIV Seropositivity, pubmed-meshheading:12626885-HIV-1, pubmed-meshheading:12626885-Hepacivirus, pubmed-meshheading:12626885-Hepatitis C, Chronic, pubmed-meshheading:12626885-Humans, pubmed-meshheading:12626885-Incidence, pubmed-meshheading:12626885-Interferons, pubmed-meshheading:12626885-Liver, pubmed-meshheading:12626885-Liver Failure, pubmed-meshheading:12626885-Male, pubmed-meshheading:12626885-Prognosis, pubmed-meshheading:12626885-Recurrence, pubmed-meshheading:12626885-Risk Factors
pubmed:year
2003
pubmed:articleTitle
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome.
pubmed:affiliation
Istituto di Malattie Infettive e Tropicali, Università degli Studi di Brescia, Italy. puoti_brambilla@iol.it
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't